CD4 and tuberculosis: Participants who initiated early ART (baseline CD4 count ≥500 cells/μL) had less advanced baseline WHO clinical stage disease, were less likely to be receiving concomitant TB treatment, and had an appreciably lower proportion of males than participants in lower CD4 count strata.